Skip to main content
Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1738792814
Post ID
urn:li:share:7293025657511366657

The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new treatment called a hybrid sinus node sparing ablation in patients with symptomatic Inappropriate Sinus Tachycardia (IST). ​​

To learn more about the HEAL-IST Trial and hybrid sinus node sparing procedure, visit: www.heal-ist.com.​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=InnapropriateSinusTachy…; target='_blank'>#InnapropriateSinusTachycardia</a>​

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQElFIO8_qNR-A/image-shrink_800/B56ZTYILSTGQAc-/0/1738792811605?e=1739818800&v=beta&t=8Dm6b1kJhxMAZDYte6en-jV-p9gVVCmjht5_ULENvqc
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7293025657511366657
Post creted timestamp